Glossary Term

IND

Investigational New Drug (IND) is a US FDA designation permitting clinical trials to begin in humans after a company demonstrates adequate preclinical safety and pharmacological evidence.

Illustration representing IND
Listen to definition
Related terms
CDER FDA GCP
Further reading
FDA: IND Application Wikipedia: Investigational New Drug Browse the HEOR resource database

Spotted an error or have a suggestion? Get in touch

Media Kit · Q2 2026

Where should we send it?

Quick details so we can email the kit and follow up if it's a fit. We use this only to talk to you about sponsorship — never sold or shared.

Your details stay with Mirko von Hein. No newsletter sign-ups, no third-party sharing.